Related Experiment Video
Updated: Aug 14, 2026

In Vitro and In Vivo Approaches to Determine Intestinal Epithelial Cell Permeability
Published on: October 19, 2018
The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat
J D Lloyd-Still1, M R Uhing, V Arango
1Department of Pediatrics, Rush Medical College, Chicago, Illinois, USA.
Insights
Excessive pancreatic enzymes combined with agents increasing intestinal permeability cause severe intestinal damage in a rat model. This finding is relevant to fibrosing colonopathy in cystic fibrosis patients.
Area of Science:
- Gastroenterology
- Pediatric Gastroenterology
- Pharmacology
Background:
- Fibrosing colonopathy affects children with cystic fibrosis (CF) aged 2-7 years.
- It is linked to excessive doses of pancreatic lipase enzymes over 6 months.
- A rat model was created to investigate these effects.
Purpose of the Study:
- To examine the impact of excessive pancreatic enzyme doses on intestinal health.
- To investigate the role of increased intestinal permeability in enzyme-induced damage.
Main Methods:
- Five rat groups received varying combinations of pancreatic enzymes, oleic acid, and reserpine.
- The study assessed the effects of these agents on the gastrointestinal tract and liver.
Main Results:
- Pancreatic enzymes alone caused minimal intestinal damage and no liver damage.
- Excessive enzymes with agents increasing intestinal permeability led to eosinophilia, jejunoileal muscle necrosis, and liver nodules.
- Damage severity correlated with the duration of the insult.
Conclusions:
- Increased intestinal permeability exacerbates intestinal damage from excessive pancreatic enzymes.
- This mechanism may contribute to fibrosing colonopathy vulnerability in cystic fibrosis.
Background:
Fibrosing colonopathy in cystic fibrosis occurs in children 2 to 7 years old and is associated with excess doses of high and regular strength lipase pancreatic enzymes, given for more than 6 months. A rat model was developed to study the effects of excessive doses of pancreatic enzymes equivalent to those producing fibrosing colonopathy in cystic fibrosis patients.
Methods:
Five groups of animals were studied after administration of different combinations of pancreatic enzymes, oleic acid, and reserpine.
Results:
Pancreatic enzymes alone produced minimal damage to the intestine and none to the liver. Excessive doses of pancreatic enzymes in combination with agents that increased intestinal permeability (oleic acid, reserpine) were associated with intestinal eosinophilia and necrosis of the jejunoileal muscle layer and inflammatory nodules in the liver, which increased with duration of insult.
Conclusions:
Increased intestinal permeability potentiates damage to the intestine caused by excessive pancreatic enzyme dosage. It is a characteristic of cystic fibrosis that may increase vulnerability to fibrosing colonopathy.
More Related Videos
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology

